Cosmo International Fragrances and Doctor Aromas partnered to develop the new Everspray technology, a next-generation of fragrance delivery though an advanced aerosol system. The companies claim that this patented innovation provides enhanced suspension, long-lasting performance and high fragrance concentration of up to 40%.
According to the press release, Everspray produces micro-droplets that remain suspended 10 to 100 times longer in the air than traditional aerosols. Further, the new technology is alcohol-free, non-flammable and has a low Global Warming Potential (GWP).
“This partnership reflects our commitment to pushing fragrance innovation into new territory,” said Marc Blaison, president of Cosmo International Fragrances. “By combining Cosmo’s expertise with Everspray’s cutting-edge technology, we’re opening doors to smarter, safer and more sensorial aerosol experiences for our clients.”
The Everspray technology recently received the SATA Innovation Award for Advancement in Formulation from the Southern Aerosol Technical Association.
“Formulating this system challenged us to rethink how we design for diffusion, suspension and fragrance intensity,” said Cosmo’s technology division director Thomas Delmas. “The result is a fully integrated solution that gives brands a cleaner, longer-lasting and more elevated way to deliver scent.”
Marcelo Zelicovich, chief executive officer of Doctor Aromas, added, “This partnership is set to transform multiple sectors — from air care to personal care and specialty scenting applications. [Cosmo’s] ability to optimize scent profiles for maximum performance unlocks the full potential of our aerosol technology. Together, we are offering superior sprayed fragrance products across key categories."
Cosmo International Fragrances will introduce the Everspray innovation at Beautyworld Middle East in October 2025.
